Skip to content
PFE Pfizer Inc NYSE
50.25 USD 1.09% +0.54
OPEN 49.81
DAY RANGE 51.15 - 49.77
52 WEEK RANGE 61.71 - 41.45
Interactive Brokers Logotype

Buy PFE stocks now with Interactive Brokers – the most advanced investment platform

Valuations metrics

Market capitalization 283.2B
Enterprise value 280.2B
Trailing pe 9.663794
Forward pe 10.1498995
Peg ratio 4.17
Price to sales ttm 2.835093
Price to book mrq 3.0561612
Enterprise to revenue 2.805
Enterprise to ebitda 6.26


Fiscal year ends 2021-12-31
Most recent quarter 2022-10-02
Profit margin 0.29806998
Operating margin 0.39956
Return on assets ttm 0.13319
Return on equity ttm 0.35507
Income statement
Revenue ttm 99.9B
Revenue per share ttm 17.811
Quarterly revenue growth -0.058
Gross profit ttm 50.6B
Ebitda 43B
Net income to common ttm 30B
Diluted eps ttm 5.22
Quarterly earnings growth yoy 0.057
Balance sheet
Revenue ttm 99.9B
Total cash mrq 36.1B
Total cash per share mrq 6.437
Total debt mrq 37B
Total debt to equity mrq 39.831
Current ratio mrq 1.589
Book value per share mrq 16.506
Cash flow
Operating cash flow ttm 26.6B
Levered free cash flow ttm 22.8B

Stock statistics

Shares outstanding 5.6B
Float shares 5.6B
Avg 10 volume 17.1M
Avg 30 volume 20M
Shares short 70M
Short ratio 3.04
Short percent of shares outstanding 0.0125
Percent held by insiders 0.00045000002
Percent held by institutions 0.70496005

Stock price summary

Fifty two week low 41.45
Fifty two week high 61.71
Fifty two week change -2.289
Beta 0.651221
Day 50 ma 46.322
Day 200 ma 49.09395

Dividends and splits

Forward annual dividend rate 1.6
Forward annual dividend yield 0.0322
Trailing annual dividend rate 1.59
Trailing annual dividend yield 0.031985518
5 year average dividend yield 3.59
Payout ratio 0.3046
Dividend date 2022-12-05
Ex dividend date 2022-11-03
Last split factor 1054-for-1000 split
Last split date 2020-11-17

Pfizer Inc. (PFE) Company Profile

Pfizer is an American multinational pharmaceutical company that develops, manufactures, and sells healthcare products globally. The pharmaceutical company was founded in 1849 by Charles F. Erhart and Charles Pfizer in New York. The Company went public in June 1942, and it trades on the New York Stock Exchange (NYSE) under the ticker PFE. 

Pfizer’s product portfolio includes medicines and vaccines. The Company manages operations through two business segments:

  • Pfizer Innovative Health (IH) segment focuses on developing and commercializing medicines and vaccines globally. The IH therapeutic sector comprises internal medicine, vaccines, oncology, inflammation and immunology, rare diseases, and consumer healthcare.
  • Pfizer Essential Health (EH) segment includes legacy brands, branded generics, generic sterile injectable products, biosimilars, and infusion systems. Furthermore, EH also consists of a research and development (R&D) organization and its contract manufacturing business.

Common Pfizer brands include Prevnar 13, Xeljanz, Eliquis, Lipitor, Celebrex, Pristiq, and Viagra. 

Pfizer’s main competitors 

  • Merck & Co.
  • Novartis AG
  • Eli Lilly & Co
  • Bristol Myers Squibb
  • Johnson & Johnson

Key Pfizer milestones 

In December 2020, Pfizer’s coronavirus vaccine was the first to be approved in the United Kingdom. This is after the company reported an over 95% success rate. 

In 2000, Pfizer acquired Warner-Lambert for $111.8 billion. The deal at the time created the second-largest pharmaceutical company in the world. Warner-Lambert was a Philadelphia drug company known for inventing a tablet-coating.

In 2018, Pfizer signed a deal with the German biotechnology company BioNTech, to conduct joint research and development activities. Under the agreement, Pfizer would assume sole responsibility for further clinical development and commercialization of mRNA-based flu vaccines. The collaborative partnership was credited with the development of the coronavirus vaccine. 

Between 2010 and 2011, Pfizer recorded one of its biggest revenues in history at $65.16 billion and $65.25 billion, respectively. 

Pfizer Frequently Asked Questions

How often does Pfizer pay dividends?

Pfizer pays dividends four times per year, excluding specials. Typically, dividends cover is approximately 2.0.

Has Pfizer split its stock?

In the company’s history, Pfizer has split its stock six times. The 6th split took place on November 17, 2020.

Why is Pfizer successful?

Pfizer’s success is based on continuous research and development as well as long-term planning. Pfizer constantly offers effective medicines in the fight against and prevention of diseases.